Related Experiment Video
Updated: Jun 6, 2025

06:59
Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples
Published on: June 30, 2018
7.3K
Development and validation of a portable device for lab-free versatile nucleic acid extraction
Anthony J Politza1, Tianyi Liu2, Aneesh Kshirsagar2
1Department of Biomedical Engineering, Pennsylvania State University, University Park, PA, USA.
Biotechniques
|December 2, 2024
Summary
A new portable device enables lab-free nucleic acid extraction for point-of-care diagnostics. This innovation improves the sensitivity and reliability of nucleic acid testing (NAT) in diverse settings.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Point-of-Care Testing
Background:
- Nucleic acid testing (NAT) is crucial for diagnostics but hindered by complex sample preparation.
- Existing methods often require laboratory settings, limiting on-site diagnostic capabilities.
- There is a significant need for efficient, lab-free sample preparation for point-of-care NAT.
Purpose of the Study:
- To develop a portable, battery-powered device for lab-free nucleic acid extraction.
- To evaluate the performance of low centrifugal forces with commercial chemistries for sample preparation.
- To enable reliable on-site nucleic acid extraction for point-of-care diagnostic applications.
Main Methods:
- Designed and tested a portable, battery-powered device for nucleic acid extraction.
- Utilized low centrifugal forces combined with existing commercial reagents.
- Validated reagent stability for up to 6 months.
- Compared device performance against a benchtop centrifuge using HIV RNA and SARS-CoV-2 RNA samples.
Main Results:
- The portable device demonstrated excellent agreement with benchtop centrifuge results across various sample types (buffer, plasma, saliva).
- Reagents showed stability for 6 months, indicating strong deployment potential.
- The device enables efficient, lab-free nucleic acid extraction.
Conclusions:
- The developed portable device offers a viable solution for on-site sample preparation in NAT.
- This technology can enhance the sensitivity and reliability of point-of-care diagnostics.
- Widespread adoption can benefit NAT, next-generation sequencing, biomarker detection, and environmental monitoring.

